Background: Adjunct human papillomavirus (HPV) testing with cervical cytology (Pap test) is
one option that can increase screening intervals for women aged≥ 30 years who have …

Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …

Abstract In the United States, 12,000 women are diagnosed with cervical cancer each year,
even though the screening for this disease is safe and effective. There are 3 types of …

Background: Cervical cancer screening has shifted toward human papillomavirus (HPV)-
based testing, but uptake of primary HPV screening in the United States is unknown and …

Background: Current clinical guidelines recommended primary human papillomavirus (HPV)
screening for cervical cancer testing. Previous studies reported patient-level barriers (eg …

Cervical cancer screening algorithms have changed with the introduction of testing for
human papillomavirus (HPV) and better understanding of the natural history of HPV. This …

Purpose: To provide evidence-based information that will guide nurse practitioners in
instituting the most current cervical cancer screening recommendations. Data sources: A …

Background: Since 2003, newer cervical cancer screening guidelines that include human
papillomavirus (HPV) testing with cytology (HPV co-testing) call for extension of screening …

In its 2009 recommendations for cervical cancer screening, the American College of
Obstetricians and Gynecologists (ACOG) calls for less-frequent but smarter screening that …

OBJECTIVE: To explore attitudes toward new cervical cancer screening options and
understand factors associated with those beliefs among women in routine gynecologic care …